Previous Close | 161.77 |
Open | 163.12 |
Bid | 160.77 x 100 |
Ask | 161.65 x 100 |
Day's Range | 161.08 - 163.18 |
52 Week Range | 111.20 - 187.61 |
Volume | |
Avg. Volume | 141,351 |
Market Cap | 5.789B |
Beta (5Y Monthly) | 1.35 |
PE Ratio (TTM) | 84.00 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BEDFORD, Mass., May 07, 2024--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2024.
BEDFORD, Mass., May 01, 2024--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024, in New York, NY.
BEDFORD, Mass., April 19, 2024--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.